Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh, Juned Islam, Javad Khan, et al.
CNS Drugs (2020) Vol. 34, Iss. 12, pp. 1229-1251
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The emerging tale of microglia in psychiatric disorders
Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1-29
Closed Access | Times Cited: 81
A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
Piotr Marcinowicz, Magdalena Więdłocha, Natalia Zborowska, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2488-2488
Open Access | Times Cited: 66
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 56
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, et al.
Pharmacological Research (2022) Vol. 176, pp. 106078-106078
Open Access | Times Cited: 40
Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions
Chuanjun Zhuo, Hongjun Tian, Xueqin Song, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Microglial contribution to the pathology of neurodevelopmental disorders in humans
Rugilė Matulevičiūtė, Elizabeth Toyin Akinluyi, Tim A.O. Muntslag, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 5, pp. 663-683
Open Access | Times Cited: 24
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
Hayley F. North, Christin Weissleder, Janice M. Fullerton, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 55
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis
Benedicto Crespo‐Facorro, Miguel Ruiz‐Veguilla, Javier Vázquez‐Bourgon, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation
Hayley F. North, Christin Weissleder, Janice M. Fullerton, et al.
Schizophrenia Research (2022) Vol. 248, pp. 208-218
Closed Access | Times Cited: 20
Microglia sequelae: brain signature of innate immunity in schizophrenia
Ana Catarina Rodrigues‐Neves, António Francisco Ambrósio, Catarina A. Gomes
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Histological examination of choroid plexus epithelia changes in schizophrenia
Matthew Williams, C.M. Macdonald, Federico Turkheimer
Brain Behavior and Immunity (2023) Vol. 111, pp. 292-297
Open Access | Times Cited: 11
Aripiprazole as protector against COVID-19 mortality
C. Loucera-Muñecas, Manuel Canal‐Rivero, Miguel Ruiz‐Veguilla, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Influence of antipsychotic drugs on microglia-mediated neuroinflammation in schizophrenia: perspectives in an astrocyte–microglia co-culture model
Timo Jendrik Faustmann, Franco Corvace, Pedro M. Faustmann, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Urolithin A alleviates schizophrenic-like behaviors and cognitive impairment in rats through modulation of neuroinflammation, neurogenesis, and synaptic plasticity
Zhengyuan Huang, Zhongyu Ren, Sanwang Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 446-446
Open Access | Times Cited: 21
Antipsychotic drug use complicates assessment of gene expression changes associated with schizophrenia
Anton Schulmann, Stefano Marenco, Marquis P. Vawter, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models
Hiram Tendilla‐Beltrán, Nydia del Carmen Sanchez-Islas, Mauricio Marina-Ramos, et al.
Progress in Neurobiology (2020) Vol. 199, pp. 101967-101967
Closed Access | Times Cited: 23
Gene expression profiling of monocytes in recent-onset schizophrenia
Raphael Kübler, Paul R. Ormel, Iris E. Sommer, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 334-342
Open Access | Times Cited: 7
Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
Andrea Amerio, Luca Magnani, Gabriele Arduino, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 7, pp. 1233-1247
Closed Access | Times Cited: 5
Plasma complement component 4 alterations in patients with schizophrenia before and after antipsychotic treatment
Jingfeng Su, Feng Xia, Kaiyuan Chen, et al.
Asian Journal of Psychiatry (2022) Vol. 73, pp. 103110-103110
Closed Access | Times Cited: 8
Prenatal Immune Challenge Differentiates the Effect of Aripiprazole and Risperidone on CD200–CD200R and CX3CL1–CX3CR1 Dyads and Microglial Polarization: A Study in Organotypic Cortical Cultures
Katarzyna Chamera, Katarzyna Curzytek, Kinga Kamińska, et al.
Life (2024) Vol. 14, Iss. 6, pp. 721-721
Open Access | Times Cited: 1
Effects of IL-6/IL-6R axis alterations in serum, plasma and cerebrospinal fluid with the schizophrenia: an updated review and meta-analysis of 58 studies
Thelma Beatriz González‐Castro, Carlos Alfonso Tovilla‐Zárate, Isela Esther Juárez‐Rojop, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 3, pp. 525-537
Closed Access | Times Cited: 3
Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics
Fernando Facal, Manuel Arrojo, Eduardo Paz, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 2, pp. 139-150
Closed Access | Times Cited: 5
Increased NLRP3 inflammasome expression in peripheral blood mononuclear cells of patients with schizophrenia: a case-control study
Güli̇n Özdamar Ünal, Kuyaş Hekımler Öztürk, Huseyin Emre Inci
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 2, pp. 111-117
Closed Access | Times Cited: 5
Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?
Udo Bonnet, Georg Juckel, Norbert Scherbaum, et al.
Pharmacopsychiatry (2021) Vol. 54, Iss. 03, pp. 142-143
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top